ArticleEuropean radiology2026
Three-dimensional MRI reconstruction of diaphragmatic defects in fetuses with congenital diaphragmatic hernia and mortality prediction.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic significance of cardiac magnetic resonance parameters in hypertrophic cardiomyopathy: a multicentre study.The international journal of cardiovascular imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesThis study aimed to evaluate diaphragmatic defects in fetuses with congenital diaphragmatic hernia (CDH) using three-dimensional (3D) MRI reconstruction for visualization and quantification, and to investigate its correlation with neonatal mortality. MATERIALS AND
methodsIn this retrospective diagnostic accuracy study, fetuses with prenatally diagnosed left-sided CDH (LCDH) underwent 3D reconstruction of the diaphragm and defect using ITK-SNAP software. The defect-to-diaphragm ratio (DDR) was calculated from measured sizes of the diaphragm and defect. We assessed the correlation between DDR and intraoperative Congenital Diaphragmatic Hernia Study Group (CDHSG) classification, investigated the prognostic value of DDR for neonatal mortality, and compared its predictive performance with that of observed/expected total fetal lung volume (o/e TFLV), percentage of predicted lung volume (PPLV), and observed/expected lung-to-head ratio (o/e LHR).
resultsNinety fetuses with LCDH underwent diaphragmatic 3D reconstruction and DDR measurement. The prenatal 3D MRI-based CDHSG classification showed substantial agreement with the intraoperative CDHSG classification (weighted kappa = 0.829; p < 0.001). Higher DDR was associated with lower neonatal survival in Kaplan-Meier analysis. The DDR (AUC = 0.919; 95% CI: 0.862-0.977) demonstrated comparable predictive value to other imaging indicators, including o/e TFLV (AUC = 0.905; 95% CI: 0.846-0.965), PPLV (AUC = 0.884; 95% CI: 0.814-0.953), and o/e LHR (AUC = 0.881; 95% CI: 0.812-0.951), in predicting neonatal mortality.
conclusion3D MRI reconstruction enables visualization and quantitative assessment of diaphragmatic defects in fetuses with CDH. DDR is a valuable predictor of neonatal mortality and may aid prenatal risk stratification. KEY POINTS: Question The lack of an objective prenatal method for assessing diaphragmatic defect severity in CDH is addressed through 3D fetal MRI reconstruction. Findings The DDR obtained from 3D MRI correlates with intraoperative CDHSG classification and is a significant predictor of neonatal mortality. Clinical relevance DDR enables prenatal quantification of diaphragmatic defect severity and is associated with neonatal survival, offering a prenatal and objective alternative to postnatal CDHSG classification. These advantages support its utility in risk stratification and perinatal management.
Indexed as
Identifiers
41284033What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.